Results 301 to 310 of about 780,677 (341)
Correction for Ritz et al., Social anxiety disorder-associated gut microbiota increases social fear. [PDF]
Proc Natl Acad Sci U S Aeuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2017
Key Clinical PointsSocial Anxiety Disorder Social anxiety disorder affects up to 13% of the U.S. population and is characterized by an intense fear of social situations in which the person anticipates being evaluated negatively. Social anxiety is associated with an increased risk of other mental disorders, such as depression and substance-use disorder.
Falk, Leichsenring, Frank, Leweke
+5 more sources
Key Clinical PointsSocial Anxiety Disorder Social anxiety disorder affects up to 13% of the U.S. population and is characterized by an intense fear of social situations in which the person anticipates being evaluated negatively. Social anxiety is associated with an increased risk of other mental disorders, such as depression and substance-use disorder.
Falk, Leichsenring, Frank, Leweke
+5 more sources
Medical Clinics of North America, 2001
In 1990s, it was found that GSAD is more common, more disabling, and more chronic than previously realized. For the first time, there are good data about a range of effective treatment options that can offer these patients substantial relief and protection from their disability.
B A, Raj, D V, Sheehan
openaire +3 more sources
In 1990s, it was found that GSAD is more common, more disabling, and more chronic than previously realized. For the first time, there are good data about a range of effective treatment options that can offer these patients substantial relief and protection from their disability.
B A, Raj, D V, Sheehan
openaire +3 more sources
CNS Drugs, 2005
Social anxiety disorder (SAD) is a prevalent and disabling disorder associated with significant co-morbidity. An increased awareness of SAD over the past two decades has given impetus to advances in the pharmacotherapeutic and psychotherapeutic treatment options for this disorder.
Jacqueline E, Muller +3 more
openaire +3 more sources
Social anxiety disorder (SAD) is a prevalent and disabling disorder associated with significant co-morbidity. An increased awareness of SAD over the past two decades has given impetus to advances in the pharmacotherapeutic and psychotherapeutic treatment options for this disorder.
Jacqueline E, Muller +3 more
openaire +3 more sources
Social Anxiety and Social Anxiety Disorder
Annual Review of Clinical Psychology, 2013Research on social anxiety and social anxiety disorder has proliferated over the years since the explication of the disorder through cognitive-behavioral models. This review highlights a recently updated model from our group and details recent research stemming from the (a) information processing perspective, including attention bias, interpretation ...
Amanda S, Morrison, Richard G, Heimberg
openaire +2 more sources
2018
The chapter discusses social anxiety disorder (SAD) or “social phobia”, a condition marked by persistent fears and/or anxieties about social situations (including public speaking and other types of performance) that expose the person to scrutiny by others.
+5 more sources
The chapter discusses social anxiety disorder (SAD) or “social phobia”, a condition marked by persistent fears and/or anxieties about social situations (including public speaking and other types of performance) that expose the person to scrutiny by others.
+5 more sources
This 2nd edition exploring social anxiety disorder (SAD) in the Advances in Psychotherapy series incorporates the latest theory and research on its presentation, prevalence, assessment, and treatment. The authors expertly guide mental health or healthcare professionals at any level of experience through the models for understanding this common ...
Karen Rowa, Martin M. Antony
+5 more sources
Karen Rowa, Martin M. Antony
+5 more sources